US Broker Ratings

AbCellera Biologics Inc. (ABCL) Stock Analysis: Uncovering a 97.74% Potential Upside

Investors are keeping a close watch on AbCellera Biologics Inc. (NASDAQ: ABCL), a Canadian biotechnology company that has shown significant promise in the healthcare sector. With..

Cogent Biosciences, Inc. (COGT) Stock Analysis: A Promising 65.81% Upside in the Biotech Space

Cogent Biosciences, Inc. (COGT), a prominent player in the biotechnology sector, continues to capture the attention of investors with its focus on precision therapies for genetically..

Day One Biopharmaceuticals, Inc (DAWN): Investor Outlook on a Potential 226.71% Upside

Day One Biopharmaceuticals, Inc (NASDAQ: DAWN) is capturing investor attention with its significant upside potential. As a commercial-stage biotechnology firm, Day One is on a mission..

Arbutus Biopharma Corporation (ABUS): A Biotech Pioneer with 18.53% Potential Upside

Arbutus Biopharma Corporation (NASDAQ: ABUS) stands out in the biotechnology sector with a focus on developing innovative therapeutics for infectious diseases. With its headquarters in Warminster,..

Akso Health Group (AHG) Stock Analysis: Unpacking the 415.8% Revenue Growth in a Competitive Healthcare Sector

Akso Health Group (NASDAQ: AHG) has garnered significant attention in the healthcare sector with its remarkable revenue growth of 415.8%. As a key player in the..

Oculis Holding AG (OCS) Stock Analysis: Eyeing a 114% Potential Upside with Cutting-Edge Biotech Innovations

Oculis Holding AG (NASDAQ: OCS), a burgeoning name in the biotechnology sector, is capturing investor attention with a potential upside of 114.40%. As a Swiss-based clinical-stage..

Vir Biotechnology, Inc. (VIR) Stock Analysis: A 232% Potential Upside Beckons Investors

Vir Biotechnology, Inc. (NASDAQ: VIR), a clinical-stage biopharmaceutical company, is drawing significant attention from investors eager to tap into the healthcare sector’s potential. With an impressive..

GH Research PLC (GHRS) Stock Analysis: A Biotech Powerhouse with 148% Upside Potential

GH Research PLC (NASDAQ: GHRS), a leader in the biotechnology sector, is making waves with its innovative approach to treating depression and other psychiatric disorders. Founded..

Immunome, Inc. (IMNM) Stock Analysis: A Biotech Pioneer with 141.62% Potential Upside

Immunome, Inc. (Nasdaq: IMNM) has been capturing investor attention with impressive potential upside and a robust lineup of cancer therapies. Operating within the biotechnology sector, Immunome..

Pharvaris N.V. (PHVS) Stock Analysis: Evaluating the 38.67% Potential Upside in the Biotech Sector

Pharvaris N.V. (NASDAQ: PHVS) has captured the attention of investors with its robust potential upside, estimated at 38.67%, according to current analyst ratings. This Switzerland-based biotechnology..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: A Potential 112.89% Upside in the Biotech Sector

ArriVent BioPharma, Inc. (NASDAQ: AVBP), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with a potential upside that could attract savvy investors. With..

Ardelyx, Inc. (ARDX) Investor Outlook: Exploring a Potential 77% Upside in the Biotechnology Sector

Ardelyx, Inc. (NASDAQ: ARDX) has been capturing the attention of investors within the biotechnology space, driven by its promising product pipeline and significant potential upside. With..

Replimune Group, Inc. (REPL) Stock Analysis: Navigating a 34.87% Potential Upside in Oncolytic Immunotherapy

Replimune Group, Inc. (NASDAQ: REPL), a promising player in the biotechnology sector, is garnering attention with a notable 34.87% potential upside according to analyst ratings. This..

Taysha Gene Therapies (TSHA) Stock Analysis: A Promising 189.86% Potential Upside for Biotech Investors

Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is generating buzz in the biotech sector, capturing investor attention with its impressive projected upside of 189.86%. This clinical-stage biotechnology..

CeriBell, Inc. (CBLL) Stock Analysis: A Promising 138.85% Upside Potential in the Medical Device Sector

CeriBell, Inc. (NASDAQ: CBLL) is capturing investor attention with its innovative strides in the healthcare sector, specifically within the medical devices industry. Headquartered in Sunnyvale, California,..

Avadel Pharmaceuticals plc (AVDL): Analyst Consensus Points to Strong Upside Potential

Avadel Pharmaceuticals plc (NASDAQ: AVDL) has garnered significant attention from investors following a robust surge in its stock price, currently trading at $16.23. This momentum is..

STAAR Surgical Company (STAA) Stock Analysis: Navigating the High-Valuation Terrain Amidst Revenue Challenges

STAAR Surgical Company (NASDAQ: STAA), a leading player in the healthcare sector specializing in medical instruments and supplies, is facing a unique set of challenges and..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: A Biotech Gem with 232% Potential Upside

Nurix Therapeutics, Inc. (NASDAQ: NRIX) is a clinical-stage biopharmaceutical company that has captured the attention of investors with its innovative approach to drug development. Specializing in..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: A Potential 251% Upside in the Biotech Sector

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company, is making waves in the healthcare sector with its focus on developing innovative treatments for inflammatory bowel..

SI-BONE, Inc. (SIBN) Investor Outlook: Analyst Ratings Suggest 64.69% Upside Potential

SI-BONE, Inc. (SIBN), a dynamic player in the healthcare sector focusing on medical devices, presents an intriguing opportunity for investors looking to capitalize on the innovative..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds